A model immunization programme to control Japanese encephalitis in Viet Nam

Nguyen Thu Yen1, Wei Liu2, Hoang Duc Hanh3

  • 1National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Viet Nam.

Insights

Expanding Japanese encephalitis (JE) vaccination to children aged 1-9 years significantly reduced JE incidence, particularly in the 5-9 age group. This suggests a policy change to include older children in JE immunization programs is warranted.

Area of Science:

  • * Public Health
  • * Vaccinology
  • * Epidemiology

Background:

  • * The existing Japanese encephalitis (JE) vaccine program in Vietnam, targeting children under 5 years old with three pediatric doses since 1997, has not sufficiently reduced JE incidence.
  • * High JE rates persist, notably in the 5-9 year-old demographic, indicating a gap in the current vaccination strategy.

Purpose of the Study:

  • * To evaluate the feasibility and impact of a modified JE immunization program.
  • * To assess the effectiveness of administering JE vaccine to children aged 1-9 years using a three-dose regimen with adjusted pediatric and adult doses.

Main Methods:

  • * Implementation of a model JE immunization program in selected districts targeting children aged 1-9 years.
  • * Utilized a three-dose regimen: pediatric doses for those under 3 years and adult doses for those 3 years and older.
  • * Achieved a high immunization coverage of 96.2% with at least two vaccine doses among targeted children.

Main Results:

  • * Districts participating in the model program experienced a substantial decline in JE incidence rates, from 11.32 to 0.87 per 100,000.
  • * The most significant reduction in JE incidence was observed in the 5-9 year-old age group.
  • * The model program demonstrated high vaccine uptake, with 96.2% of targeted children receiving two or more doses.

Conclusions:

  • * Expanding JE vaccination to include children up to 9 years old is effective in reducing disease incidence.
  • * A policy recommendation to incorporate 5-9 year olds into catch-up immunization campaigns is proposed.
  • * Administering a fourth JE vaccine dose to children aged 5-9 who received the initial three doses early in life is suggested for sustained protection.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
42
Vaccinations01:51

Vaccinations

Overview
54.6K
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
75
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
137